>Is Multiple Sclerosis not anymore a hot item [for Merrimack]?<
Evidently not. Merrimack completed a phase-1 MM-093 trial in healthy volunteers 3-1/2 years ago (#msg-17646219) but has not elected to run a phase-2 program in MS. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”